Publication | Closed Access

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

Hematological MalignancySecond-line Rituximab-containing ChemoimmunotherapyLymphoid NeoplasiaMedicineImmunologyHematologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyAgmt Cll-8a MabtenanceFinal ResultsHealth Sciences